Investor Engagement Brief on Nature – Biotech & Pharmaceutical Sector
Next in the Investor Engagement Series - we're pleased to launch a new Investor Engagement Brief on Nature focused on the Chemicals sector, one of the eight high-impact sectors identified by Nature Action 100 (NA100).